Recruiting Alopecia Studies in Manhattan Beach
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
This study will evaluate the safety and efficacy of VDPHL01 in female subjects with Androgenetic Alopecia (AGA). AGA is a genetic disorder caused by an excessive (too much) hair follicle response to ...
Safety and Efficacy of VDPHL01 in Males With AGA
This study will evaluate the safety and efficacy of VDPHL01 in male subjects with Androgenetic Alopecia (AGA). AGA (or male pattern baldness) is a genetic disorder caused by an excessive (too much) h...
About Alopecia Clinical Trials in Manhattan Beach
Alopecia refers to hair loss from any part of the body, with alopecia areata being an autoimmune form causing patchy hair loss. It can range from small patches to total body hair loss. Treatments include JAK inhibitors, corticosteroids, and immunotherapy.
There are currently 2 alopecia clinical trials recruiting participants in Manhattan Beach, CALIFORNIA. These studies are seeking a combined 1,032 participants. Research is being sponsored by Veradermics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alopecia Clinical Trials in Manhattan Beach — FAQ
Are there alopecia clinical trials in Manhattan Beach?
Yes, there are 2 alopecia clinical trials currently recruiting in Manhattan Beach, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Manhattan Beach?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Manhattan Beach research site will contact you about next steps.
Are clinical trials in Manhattan Beach free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Manhattan Beach studies also compensate for your time and travel.
What alopecia treatments are being tested?
The 2 active trials in Manhattan Beach are testing new therapies including novel drugs, biologics, and treatment approaches for alopecia.
Data updated March 2, 2026 from ClinicalTrials.gov